Nodular histogenetic type - The most significant factor for thick melanoma: Implications for prevention

Melanoma Research

Volumn 8, Issue 5, 1998, Pages 403-411

  Bergenmar, M ^a   Ringborg, U ^a   Mansson Brahme E ^a   Brandberg, Y ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gender differences; Nodular melanoma; Prevention; Symptoms; Tumour site; Tumour thickness

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PREVENTION; CANCER REGISTRY; DIAGNOSTIC VALUE; FEMALE; HISTOGENESIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL;

EID: 0031769414     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199810000-00004     Document Type: Article

References (22)

1. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172: 902-908.
2. Balch CM, Soong S-J, Shaw HM, Milton GW. An analysis of prognostic factors in 4000 patients with cutaneous melanoma. In: Balch CM, Milton GW, eds. Cutaneous Melanoma: Clinical Management and Treatment Results Worldwide. Philadelphia: JB Lippincott, 1985: 321-352.
3. Vollmer RT. Malignant melanoma: a multivariate analysis of prognostic factors. Pathol Annu 1989; 24(1): 383-407.
4. Thörn M, Pontén F, Bergström R, Sparén P, Adami H-O. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden. J Natl Cancer Inst 1994; 86: 761-769.
5. Keefe M, MacKie RM. The relationship between risk of death from clinical stage I malignant melanoma and thickness of primary tumour: no evidence for steps in risk. Br J Cancer 1991; 64: 598-602.
6. Månsson Brahme E, Carstensen J, Erhardt K, Lagerlöf B, Ringborg D, Rutqvist LE. Prognostic factors in thin cutaneous malignant melanoma. Cancer 1994; 73: 2324-2332.
7. MacKie RM. Secondary prevention of malignant melanoma in Europe. In: MacKie RM, ed. Primary and Secondary Prevention of Malignant Melanoma. Pigment Cell, vol 11, Basel: Karger, 1996: 22-30.
8. MacKie R, Hole D, Hunter JAA, Rankin R, Evans A, McLaren K, Fallowfield M, Hutcheon A, Morris A. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. Br Med J 1995; 315: 1117-1121.
9. MacLennan R, Green AC, McLeod GRC, Martin NG. Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst 1992; 84: 1427-1432.
10. Brandberg Y, Bergenmar M, Bolund C, Michelson H, Månsson-Brahme E, Ringborg U, Sjödén P-O. Information to patients with malignant melanoma: a randomized group study. Pat Educ Couns 1994; 23: 95-105.
11. Howell DC. Statistical Methods for Psychology. Belmont: Duxbury Press, 1992.
12. Siegel S. Nonparametric Statistics for Bebavioral Sciences. Tokyo: McGraw-Hill, 1956.
13. Hersey P, Sillar R, Howe C, Burton R, Darbar S, Foster H, Collins S, Bradley D, Owens D. Factors related to the presentation of patients with thick primary melanomas. Med J Aust 1991; 154: 583-587.
14. Koh H, Miller D, Geller A, Clapp R, Mercer MB, Lew R. Who discovers melanoma?. J Am Acad Dermatol 1992; 26: 914-919.
15. Titus-Ernstoff L, Thörn M, Tosteson TD, Mansson Brahme E, Yuen J, Baron JA, Adami HO. The accuracy of skin self-examination for atypical nevi. Epidemiology 1996; 7: 619-623
16. Muhn CY, From L, Glied M. Detection of change in mole size by skin self examination. Melanoma Res 1997; 7(suppl 1): 61.
17. Hanrahan PF, Hersey P, Menzies SW, Watson AB, D'Este CA. Examination of the ability of people to identity early changes of melanoma in computer-altered pigmented skin lesions. Arch Dermatol 1997; 133: 301-311.
18. Doherty VR, MacKie RM. Reasons for poor prognosis in British patients with cutaneous malignant melanoma. Br Med J 1986; 292: 987-989.
19. Temoshok L, DiClemente R, Sweet D, Blois M, Sagebiel R. Factors related to patients delay in seeking medical attention for cutaneous malignant melanoma. Cancer 1984; 54: 3048-3053.
20. Grob JJ, Richard MA, Avril MF, Thirion X, Delaunay M, Revuz J, Souteyrand P, Dreno B, Lambert D, Lorette G, Guillaume JC, Chevrant-Breton J, Vilmer C, Humbert P, Guillot B, Beylot C, Denoeux E, Dubertret, Bonerandi JJ. Impact of delay in melanoma diagnosis on prognosis: limits of prevention. Melanoma Res 1997; 7(suppl 1): 61.
21. Brandberg Y, Bolund C, Michelson H, Mansson-Brahme E, Ringborg U, Sjöden P-O. Perceived susceptibility to and knowledge of malignant melanoma: screening participants vs the general population. Prev Med 1996; 25: 170-177.
22. Brandberg Y, Ullén H., Sjöberg L, Holm L.E. Sunbathing and sunbed use related to self-image in a randomized sample of Swedish adolescents Eur J Cancer Prev 1998; in press